Alkem Laboratories Limited has informed the Exchange regarding Cessation of Mr Rakesh Tripathi as Senior Management Position of the Company w.e.f. December 08, 2025.
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkem Laboratories has informed the stock exchange that Mr Rakesh Tripathi has ceased to hold his Senior Management Position with the company, effective December 8, 2025. No specific reason for the departure has been disclosed in this filing. The role affected is described as a Senior Management Position, not the CEO or CFO position. No replacement or successor details have been mentioned in this particular announcement.
This is a routine senior management exit and does not directly affect the company's top leadership (CEO/CFO). Shareholders should watch for further filings if the role being vacated is critical to operations or if multiple exits follow.